GLO1 and breast carcinoma: Hence, Glo1 overexpression correlated with aggressive clinicopathological features including lymph node metastasis, lymphovascular invasion, tumor grade and TNM stage and was an independent prognostic factor for clinical outcome of breast cancer patients.